Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Provided herein are novel pyrazolopyrazine compounds as SHP2 inhibitors, pharmaceutical compositions, use of such compounds in treating glioblastoma, and processes for preparing such compounds.
Keyphrases